{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:20:25Z","timestamp":1786980025235,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06434-w","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:32:54Z","timestamp":1778167974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prostate cancer therapeutic strategies decided based on in-bore MRI-targeted prostate biopsies alone, or in combination with TRUS-guided biopsies"],"prefix":"10.1007","volume":"44","author":[{"given":"Alexandre","family":"Schull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Tavolaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Santy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregoire","family":"Bornet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"6434_CR1","unstructured":"European Commission \u2018Prostate cancer factsheet in 2020 for EU-27 countries\u2019. Accessed: Oct. 21, 2025. [Online]. Available: https:\/\/ecis.jrc.ec.europa.eu\/sites\/default\/files\/2023-12\/prostate_cancer_En-Nov_2021.pdf"},{"issue":"5","key":"6434_CR2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.annonc.2020.02.009","volume":"31","author":"G Carioli","year":"2020","unstructured":"Carioli G, Bertuccio P, Boffetta P, Levi F, Vecchia C, Negri E (2020) European cancer mortality predictions for the year 2020 with a focus on prostate cancer. Ann Oncol 31(5):650\u2013658","journal-title":"Ann Oncol"},{"key":"6434_CR3","doi-asserted-by":"publisher","unstructured":"Grosclaude P et al (2015) \u2018[Prostate cancer incidence and mortality trends in France from 1980 to 2011].\u2019, Prog Urol, vol. 25, no. 9, pp. 536\u2013542, Jul. https:\/\/doi.org\/10.1016\/j.purol.2015.04.011","DOI":"10.1016\/j.purol.2015.04.011"},{"key":"6434_CR4","doi-asserted-by":"publisher","unstructured":"Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J (May 2006) Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 175(5):1605\u20131612. https:\/\/doi.org\/10.1016\/S0022-5347(05)00957-2","DOI":"10.1016\/S0022-5347(05)00957-2"},{"key":"6434_CR5","doi-asserted-by":"publisher","unstructured":"Ahmed HU et al (Feb. 2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389(10071):815\u2013822. https:\/\/doi.org\/10.1016\/S0140-6736(16)32401-1","DOI":"10.1016\/S0140-6736(16)32401-1"},{"key":"6434_CR6","doi-asserted-by":"publisher","unstructured":"Rouvi\u00e8re O et al (Jan. 2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20(1):100\u2013109. https:\/\/doi.org\/10.1016\/S1470-2045(18)30569-2","DOI":"10.1016\/S1470-2045(18)30569-2"},{"key":"6434_CR7","doi-asserted-by":"publisher","unstructured":"van der Leest M et al (2019) \u2018Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-na\u00efve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.\u2019, Eur Urol, vol. 75, no. 4, pp. 570\u2013578, Apr. https:\/\/doi.org\/10.1016\/j.eururo.2018.11.023","DOI":"10.1016\/j.eururo.2018.11.023"},{"issue":"1","key":"6434_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2214\/AJR.15.14579","volume":"206","author":"L Schimm\u00f6ller","year":"2016","unstructured":"Schimm\u00f6ller L, Blondin D, Arsov C, Rabenalt R, Albers P, Antoch G (2016) MRI-Guided In-Bore Biopsy: Differences Between Prostate Cancer Detection and Localization in Primary and Secondary Biopsy Settings. AJR Am J Roentgenol 206(1):92\u201399","journal-title":"AJR Am J Roentgenol"},{"key":"6434_CR9","doi-asserted-by":"publisher","unstructured":"Goldberg H et al (2020) \u2018Comparison of Magnetic Resonance Imaging and Transrectal Ultrasound Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy Na\u00efve Men: A Systematic Review and Meta-Analysis\u2019, Journal of Urology, vol. 203, no. 6, pp. 1085\u20131093, Jun. https:\/\/doi.org\/10.1097\/JU.0000000000000595","DOI":"10.1097\/JU.0000000000000595"},{"key":"6434_CR10","doi-asserted-by":"publisher","unstructured":"Kasivisvanathan V et al (2019) Sep., \u2018Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.\u2019, Eur Urol, vol. 76, no. 3, pp. 284\u2013303. https:\/\/doi.org\/10.1016\/j.eururo.2019.04.043","DOI":"10.1016\/j.eururo.2019.04.043"},{"key":"6434_CR11","doi-asserted-by":"publisher","unstructured":"Derigs F et al (Feb. 2022) A prospective study on inter-operator variability in semi-robotic software-based MRI\/TRUS-fusion targeted prostate biopsies. World J Urol 40(2):427\u2013433. https:\/\/doi.org\/10.1007\/s00345-021-03891-3","DOI":"10.1007\/s00345-021-03891-3"},{"key":"6434_CR12","doi-asserted-by":"publisher","unstructured":"Hanske J et al (2022) \u2018Comparison of prostate cancer detection rates in patients undergoing MRI\/TRUS fusion prostate biopsy with two different software-based systems.\u2019, Prostate, vol. 82, no. 2, pp. 227\u2013234, Feb. https:\/\/doi.org\/10.1002\/pros.24264","DOI":"10.1002\/pros.24264"},{"key":"6434_CR13","doi-asserted-by":"publisher","unstructured":"Jager A, Vilanova JC, Michi M, Wijkstra H, Oddens JR (Mar. 2022) The challenge of prostate biopsy guidance in the era of mpMRI detected lesion: ultrasound-guided versus in-bore biopsy. Br J Radiol 95(1131):20210363. https:\/\/doi.org\/10.1259\/bjr.20210363","DOI":"10.1259\/bjr.20210363"},{"key":"6434_CR14","doi-asserted-by":"publisher","unstructured":"Watts KL et al (2020) Sep., \u2018Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer \u00bb\u2019, Urologic Oncology: Seminars and Original Investigations, vol. 38, no. 9, p. 734 19\u2013734 25. https:\/\/doi.org\/10.1016\/j.urolonc.2020.03.020","DOI":"10.1016\/j.urolonc.2020.03.020"},{"key":"6434_CR15","doi-asserted-by":"publisher","unstructured":"Wegelin O et al (2017) \u2018Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?\u2019, Eur Urol, vol. 71, no. 4, pp. 517\u2013531, Apr. https:\/\/doi.org\/10.1016\/j.eururo.2016.07.041","DOI":"10.1016\/j.eururo.2016.07.041"},{"key":"6434_CR16","doi-asserted-by":"publisher","unstructured":"Wegelin O et al (2019) \u2018The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.\u2019, Eur Urol, vol. 75, no. 4, pp. 582\u2013590, Apr. https:\/\/doi.org\/10.1016\/j.eururo.2018.11.040","DOI":"10.1016\/j.eururo.2018.11.040"},{"key":"6434_CR17","doi-asserted-by":"publisher","unstructured":"Falagario UG et al (2025) \u2018Prostate cancer detection and complications of MRI-targeted prostate biopsy using cognitive registration, software-assisted image fusion or in-bore guidance: a systematic review and meta-analysis of comparative studies.\u2019, Prostate Cancer Prostatic Dis, vol. 28, no. 2, pp. 270\u2013279, Jun. https:\/\/doi.org\/10.1038\/s41391-024-00827-x","DOI":"10.1038\/s41391-024-00827-x"},{"key":"6434_CR18","doi-asserted-by":"publisher","unstructured":"Barral M et al (2019) \u2018In-Bore Transrectal MRI-Guided Biopsy With Robotic Assistance in the Diagnosis of Prostate Cancer: An Analysis of 57 Patients.\u2019, AJR Am J Roentgenol, vol. 213, no. 4, pp. W171\u2013W179, Oct. https:\/\/doi.org\/10.2214\/AJR.19.21145","DOI":"10.2214\/AJR.19.21145"},{"key":"6434_CR19","doi-asserted-by":"publisher","unstructured":"Vilanova JC et al (2020) \u2018Robotic-assisted transrectal MRI-guided biopsy. Technical feasibility and role in the current diagnosis of prostate cancer: an initial single-center experience.\u2019, Abdom Radiol (NY), vol. 45, no. 12, pp. 4150\u20134159, Dec. https:\/\/doi.org\/10.1007\/s00261-020-02665-6","DOI":"10.1007\/s00261-020-02665-6"},{"key":"6434_CR20","first-page":"F394","volume":"7","author":"Association Francaise d\u2019Urologie","year":"2024","unstructured":"Association Francaise d\u2019Urologie (2024) French AFU Cancer Committee Guideline \u2013 Update 2024\u20132026: Prostate cancer \u2013 Diagnosis and management of localised disease. Progr\u00e8s FMC 7:34, F394","journal-title":"Progr\u00e8s FMC"},{"key":"6434_CR21","doi-asserted-by":"publisher","unstructured":"De Rooij M et al (May 2024) PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI. Eur Radiol 34(11):7068\u20137079. https:\/\/doi.org\/10.1007\/s00330-024-10795-4","DOI":"10.1007\/s00330-024-10795-4"},{"issue":"1","key":"6434_CR22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The Measurement of Observer Agreement for Categorical Data. Biometrics 33(1):159\u2013174. https:\/\/doi.org\/10.2307\/2529310","journal-title":"Biometrics"},{"key":"6434_CR23","doi-asserted-by":"publisher","unstructured":"Venderink W et al (2017) \u2018Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer\u2019, World J Urol, vol. 35, no. 12, pp. 1849\u20131855, Dec. https:\/\/doi.org\/10.1007\/s00345-017-2085-6","DOI":"10.1007\/s00345-017-2085-6"},{"key":"6434_CR24","doi-asserted-by":"publisher","unstructured":"Costa DN et al (2021) \u2018Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI\u2013Transrectal US Fusion Prostate Biopsies\u2019, Radiology: Imaging Cancer, vol. 3, no. 2, p. e200123, Mar. https:\/\/doi.org\/10.1148\/rycan.2021200123","DOI":"10.1148\/rycan.2021200123"},{"key":"6434_CR25","doi-asserted-by":"publisher","unstructured":"Prince M et al (2021) \u2018In-Bore Versus Fusion MRI\u2013Targeted Biopsy of PI-RADS Category 4 and 5 Lesions: A Retrospective Comparative Analysis Using Propensity Score Weighting\u2019, American Journal of Roentgenology, vol. 217, no. 5, pp. 1123\u20131130, Nov. https:\/\/doi.org\/10.2214\/AJR.20.25207","DOI":"10.2214\/AJR.20.25207"},{"key":"6434_CR26","doi-asserted-by":"publisher","unstructured":"Arsov C et al (2015) \u2018Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.\u2019, Eur Urol, vol. 68, no. 4, pp. 713\u2013720, Oct. https:\/\/doi.org\/10.1016\/j.eururo.2015.06.008","DOI":"10.1016\/j.eururo.2015.06.008"},{"key":"6434_CR27","doi-asserted-by":"publisher","unstructured":"Kilic M, Madendere S, Vural M, Koseoglu E, Balbay MD, Esen T (2023) \u2018The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy\u2019, World Journal of Urology, vol. 41, no. 2, pp. 449\u2013454, Feb. https:\/\/doi.org\/10.1007\/s00345-022-04274-y","DOI":"10.1007\/s00345-022-04274-y"},{"key":"6434_CR28","doi-asserted-by":"publisher","unstructured":"Felker ER et al (May 2016) In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer. Abdom Radiol 41(5):954\u2013962. https:\/\/doi.org\/10.1007\/s00261-016-0750-7","DOI":"10.1007\/s00261-016-0750-7"},{"key":"6434_CR29","doi-asserted-by":"publisher","unstructured":"Pokorny M et al (2019) \u2018MRI-guided in-bore biopsy for prostate cancer: what does the evidence say? A case series of 554 patients and a review of the current literature.\u2019, World J Urol, vol. 37, no. 7, pp. 1263\u20131279, Jul. https:\/\/doi.org\/10.1007\/s00345-018-2497-y","DOI":"10.1007\/s00345-018-2497-y"},{"key":"6434_CR30","doi-asserted-by":"publisher","unstructured":"Schouten MG et al (Jun. 2017) Why and Where do We Miss Significant Prostate Cancer with Multi-parametric Magnetic Resonance Imaging followed by Magnetic Resonance-guided and Transrectal Ultrasound-guided Biopsy in Biopsy-na\u00efve Men? Eur Urol 71(6):896\u2013903. https:\/\/doi.org\/10.1016\/j.eururo.2016.12.006","DOI":"10.1016\/j.eururo.2016.12.006"},{"key":"6434_CR31","doi-asserted-by":"publisher","unstructured":"Schaudinn A et al (Mar. 2025) Prostate cancer detection with transrectal in-bore MRI biopsies: impact of prostate volume and lesion features. Insights Imaging 16(1):69. https:\/\/doi.org\/10.1186\/s13244-025-01942-6","DOI":"10.1186\/s13244-025-01942-6"},{"key":"6434_CR32","doi-asserted-by":"crossref","unstructured":"Osses DF, van Asten JJ, Tijsterman JD (2018) \u2018Cognitive-Targeted versus Magnetic Resonance Imaging-Guided Prostate Biopsy in Prostate Cancer Detection\u2019, Current Urology, vol. 11, no. 4, [Online]. Available: https:\/\/journals.lww.com\/cur\/fulltext\/2018\/11040\/cognitive_targeted_versus_magnetic_resonance.3.aspx","DOI":"10.1159\/000447216"},{"key":"6434_CR33","doi-asserted-by":"publisher","unstructured":"Pizzoli SFM et al (2020) \u2018Patients\u2019 experience with MRI-guided in-bore biopsy versus TRUS-guided biopsy in prostate cancer: a pilot study\u2019, ecancer, vol. 14, Oct. https:\/\/doi.org\/10.3332\/ecancer.2020.1127","DOI":"10.3332\/ecancer.2020.1127"},{"key":"6434_CR34","unstructured":"Cornford P, \u2018EAU - EANM - ESTRO ESUR - ISUP - SIOG Guidelines on Prostate Cancer\u2019 (2025), Accessed: Jun. 02, 2025. [Online]. Available: https:\/\/d56bochluxqnz.cloudfront.net\/documents\/full-guideline\/EAU-EANM-ESTRO-ESUR-ISUP-SIOG-Guidelines-on-Prostate-Cancer-2025_2025-03-24-120144_rinw.pdf"},{"key":"6434_CR35","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.26154","author":"SD Chang","year":"2021","unstructured":"Chang SD, Ghai S, Kim CK, Oto A, Giganti F, Moore CM (2021) MRI-Targeted Prostate Biopsy Techniques: AJR Expert Panel Narrative Review \u00bb. Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.21.26154","journal-title":"Am J Roentgenol"},{"key":"6434_CR36","doi-asserted-by":"publisher","unstructured":"Kinnaird A et al (May 2025) Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial. JAMA 333:1679\u20131687. https:\/\/doi.org\/10.1001\/jama.2025.3579","DOI":"10.1001\/jama.2025.3579"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06434-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06434-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:32:58Z","timestamp":1778167978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06434-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6434"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06434-w","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received approval from the French Committee for Protection of People (CPP Ouest V, SI Reference: 22.01640.000103; national number: 2022-A00792-41).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written informed consent to participate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"346"}}